Schedule 13D ownership disclosure

ENSYSCE BIOSCIENCES INC

Security class unavailable · CUSIP: 293602405

Event date: 2022-12-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
161,586
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-23-024765
Form type
SC 13D/A
Filer
Ensysce Biosciences, Inc.
CIK
CIK 1716947
Filed
Jul 18, 2023
Reporting period
Dec 09, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub